Description
Mechanism of Action:
✔ Activates PPAR-γ receptors, increasing insulin sensitivity in muscle, fat, and liver cells.
✔ Reduces hepatic glucose output, lowering fasting blood sugar levels.
✔ Enhances glucose uptake by cells, improving glycemic control.
Indications:
✔ Type 2 Diabetes Mellitus
✔ Patients with insulin resistance
✔ Can be used as monotherapy or combination therapy
Key Benefits:
✅ Improves insulin sensitivity for better glucose utilization
✅ Helps control fasting and postprandial blood sugar levels
✅ Reduces triglycerides and improves lipid profile
✅ Once-daily dosing for better patient compliance
Dosage & Administration:
- Recommended Dosage: 15 mg or 30 mg once daily (as prescribed).
- Route of Administration: Oral
- Food Intake: Can be taken with or without food.
Precautions & Warnings:
- Not recommended for patients with heart failure or liver disease.
- May cause fluid retention, leading to swelling or weight gain.
- Regular liver function tests are advised.
Possible Side Effects:
- Weight gain
- Swelling (edema)
- Increased risk of fractures in long-term use
Storage & Packaging:
- Store below 30°C in a cool, dry place.
- Available in blister packs and bulk packaging.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.
Global Export & Supply:
Aetos Life Care exports Pioglitazone Tablets 15 mg, 30 mg to Latin America, Africa, Asia, Europe, and CIS countries, delivering high-quality and cost-effective diabetes solutions worldwide.
